Abstract

Abstract A sequential study of urinary hydroxyproline was performed in 47 patients with cancer of the breast. The results have shown that hydroxyproline excretion in the urine provides a sensitive index of the early development of secondary deposits in bone from primary breast cancer. Elevation of the urinary excretion of hydroxyproline may predate by several months the radiological demonstration of osseous deposits. Sequential estimations have shown that the elevated urinary hydroxyproline excretion is persistent in patients who subsequently develop deposits in bone.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.